Diagnosis and treatment of cancer using anti-GPR49 antibody

Details for Australian Patent Application No. 2008321840 (hide)

Owner Forerunner Pharma Research Co., Ltd.

Inventors Funahashi, Shinichi

Agent Spruson & Ferguson

Pub. Number AU-A-2008321840

PCT Pub. Number WO2009/063970

Priority 2007-295341 14.11.07 JP

Filing date 14 November 2008

Wipo publication date 22 May 2009

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 19/00 (2006.01) Hybrid peptides

G01N 33/536 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with immune complex formed in liquid phase

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/063970 Priority application(s): WO2009/063970

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321843-Electrode substrate for photoelectric conversion element, method of manufacturing electrode substrate for photoelectric conversion element, and photoelectric conversion element

2008321835-Monoclonal antibody capable of binding to anexelekto, and use thereof